Previous 10 | Next 10 |
SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference PR Newswire PRINCETON, N.J. , May 21, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharm...
Soligenix Encourages Stockholders to Vote Prior to Annual Meeting PR Newswire Annual Meeting to be held May 23, 2024 PRINCETON, N.J. , May 20, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical c...
Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice PR Newswire Published Results Confirm and Extend Response Results from Phase 3 FLASH Study PRINCETON, N.J. , ...
2024-05-10 07:45:18 ET More on Soligenix Soligenix stock dips on pricing $4.75 million securities offering Seeking Alpha’s Quant Rating on Soligenix Historical earnings data for Soligenix Financial information for Soligenix Read the full arti...
Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results PR Newswire PRINCETON, N.J. , May 10, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing ...
Soligenix to Present at Upcoming Conferences PR Newswire PRINCETON, N.J. , May 6, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to tre...
Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa PR Newswire Includes thermostabilized Ebola vaccines MarVax™ and SuVax™ Includes nanoemulsion adjuvant compatible with lyophilization ...
2024-04-18 08:47:59 ET More on Soligenix Seeking Alpha’s Quant Rating on Soligenix Historical earnings data for Soligenix Financial information for Soligenix Read the full article on Seeking Alpha For further details see: Soligenix stock di...
Soligenix Announces Pricing of $4.75 Million Public Offering PR Newswire PRINCETON, N.J. , April 18, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializi...
2024-04-16 06:51:00 ET 3 Steps to Take Before You Start Trading Penny Stocks in 2024 Penny stocks offer an exciting opportunity for investors seeking to diversify their portfolio with high-potential investments. Trading penny stocks can be a gateway to both learning about the stock ...
News, Short Squeeze, Breakout and More Instantly...
Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma PR Newswire HyBryte™ demonstrates more rapid and robust treatment response compared to Valchlor ...
A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference PR Newswire Advanced subunit vaccine technology, including SuVax™ and MarVax™, to be discussed alongside mRNA and viral vectored vaccine approaches PRINCETON, ...
ORLANDO, FL / ACCESSWIRE / June 7, 2024 / RedChip Companies will air interviews with Soligenix, Inc. (Nasdaq:SNGX) and Sharps Technology Inc. (Nasdaq:STSS) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, June 8, at 7 p.m. Eastern Time (E...